MAXIMUS, Inc. (NYSE:MMS) Vice Chairman Richard A. Montoni sold 30,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $72.03, for a total transaction of $2,160,900.00. Following the completion of the transaction, the insider now directly owns 429,874 shares of the company’s stock, valued at approximately $30,963,824.22. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Shares of MAXIMUS stock traded down $0.52 during trading on Friday, hitting $69.86. 660,408 shares of the stock were exchanged, compared to its average volume of 432,378. The stock has a market cap of $4.51 billion, a P/E ratio of 20.55, a price-to-earnings-growth ratio of 1.92 and a beta of 1.03. MAXIMUS, Inc. has a 12-month low of $60.00 and a 12-month high of $72.71.
MAXIMUS (NYSE:MMS) last released its quarterly earnings data on Tuesday, November 20th. The health services provider reported $0.71 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.72 by ($0.01). The firm had revenue of $558.50 million for the quarter, compared to analysts’ expectations of $587.58 million. MAXIMUS had a return on equity of 20.23% and a net margin of 9.23%. MAXIMUS’s revenue for the quarter was down 10.0% on a year-over-year basis. During the same period last year, the firm posted $0.81 earnings per share. On average, sell-side analysts expect that MAXIMUS, Inc. will post 3.66 earnings per share for the current year.
Several equities analysts have commented on the stock. ValuEngine raised shares of MAXIMUS from a “hold” rating to a “buy” rating in a research report on Friday, November 30th. Zacks Investment Research raised shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 price target for the company in a research report on Friday, November 23rd. Finally, Canaccord Genuity raised their price target on shares of MAXIMUS from $64.00 to $67.00 and gave the company a “hold” rating in a research report on Wednesday, October 10th. Two research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. MAXIMUS has a consensus rating of “Buy” and a consensus target price of $72.00.
Several institutional investors have recently added to or reduced their stakes in the company. Marshall Wace LLP purchased a new stake in shares of MAXIMUS during the 3rd quarter worth $2,332,000. Clearbridge Investments LLC lifted its position in shares of MAXIMUS by 9.7% during the 3rd quarter. Clearbridge Investments LLC now owns 417,514 shares of the health services provider’s stock worth $27,163,000 after purchasing an additional 37,076 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of MAXIMUS by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 6,767,684 shares of the health services provider’s stock worth $440,305,000 after purchasing an additional 52,238 shares during the last quarter. Nordea Investment Management AB lifted its position in shares of MAXIMUS by 41.9% during the 3rd quarter. Nordea Investment Management AB now owns 71,423 shares of the health services provider’s stock worth $4,647,000 after purchasing an additional 21,092 shares during the last quarter. Finally, AQR Capital Management LLC lifted its position in shares of MAXIMUS by 29.6% during the 3rd quarter. AQR Capital Management LLC now owns 906,088 shares of the health services provider’s stock worth $58,950,000 after purchasing an additional 206,896 shares during the last quarter. 93.29% of the stock is owned by institutional investors and hedge funds.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Further Reading: SEC Filing
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.